Evidence map›Paper›PMID 29202715›Full record

ArticleBMC infectious diseases2017

Epidemiology of influenza in West Africa after the 2009 influenza A(H1N1) pandemic, 2010-2012.

Ndahwouh Talla Nzussouo, Jazmin Duque, Adebayo Abel Adedeji, Daouda Coulibaly, Samba Sow, Zekiba Tarnagda, Issaka Maman, Adamou Lagare, Sonia Makaya, Mohamed Brahim Elkory and 12 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 8 countries.

Ndahwouh Talla NzussouoInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. tallus5@yahoo.fr.ORCID 0000-0002-0473-4023
Jazmin DuqueInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Adebayo Abel AdedejiNational Influenza Reference Laboratory, Federal Ministry of Health, Abuja, Nigeria.
Daouda CoulibalyInstitut National d'Hygiene Publique (INHP), Abidjan, Côte d'Ivoire.
Samba SowCentre National d'Appui à la Lutte Contre la Maladie (CNAM), Centre pour le Développement des Vaccins du Mali (CVD), Bamako, Mali.
Zekiba TarnagdaInstitut de Recherche en Sciences de Santé (IRSS), Bobo-Dioulasso, Burkina Faso.
Issaka MamanInstitut National d'Hygiene (INH), Lome, Togo.
Adamou LagareCentre de Recherche Médicale et Sanitaire (CERMES), Niamey, Niger.
Sonia MakayaInfluenza National Reference Laboratory Lakka, Freetown, Sierra Leone.
Mohamed Brahim ElkoryInstitut National Recherche en Sante Publique (INRSP), Nouakchott, Mauritanie.
Herve Kadjo AdjeInstitut Pasteur Cȏte d'Ivoire (IPCI), Abidjan, Côte d'Ivoire.
Paul Alhassan ShiloNational Influenza Reference Laboratory, Federal Ministry of Health, Abuja, Nigeria.
Boubou TambouraCentre National d'Appui à la Lutte Contre la Maladie (CNAM), Centre pour le Développement des Vaccins du Mali (CVD), Bamako, Mali.
Assana CisseInstitut de Recherche en Sciences de Santé (IRSS), Bobo-Dioulasso, Burkina Faso.
Kossi BadziklouInstitut National d'Hygiene (INH), Lome, Togo.
Halima Boubacar MaïnassaraCentre de Recherche Médicale et Sanitaire (CERMES), Niamey, Niger.
Ahmed Ould BaraInstitut National Recherche en Sante Publique (INRSP), Nouakchott, Mauritanie.
Adama Mamby KeitaCentre National d'Appui à la Lutte Contre la Maladie (CNAM), Centre pour le Développement des Vaccins du Mali (CVD), Bamako, Mali.
Thelma WilliamsInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Ann MoenInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Marc-Alain WiddowsonInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Meredith McMorrowInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Centers for Disease Control and Prevention · USCentre Pour le Développement des Vaccins-Mali · MLInstitut National d’Hygiène Publique · CICentre de Recherche Médicale et Sanitaire · NEFederal Ministry of Health · NGInstitut de Recherche en Sciences de la Santé · BFInstitut National de Recherche en Santé Publique · MLInstitut Pasteur de Côte d'Ivoire · CI

Funding

ASSESSMENT AND IMPROVEMENT OF THE MALI INFLUENZA SURVEILLANCEU51IP000827 · IP · CVD-MALI--NATIONAL INFLUENZA CENTRE · PI SOW, SAMBA · 2013 to 2015
$1.1M
Centers for Disease Control and Prevention (CDC) - Influenza Division 5U51IP000524National Center for Immunization and Respiratory Diseases (US)/CDC Influenza Division 5U51IP000530NCIRD CDC HHS U51 IP000827
6 · The paper itself

Abstract

backgroundOver the last decade, capacity for influenza surveillance and research in West Africa has strengthened. Data from these surveillance systems showed influenza A(H1N1)pdm09 circulated in West Africa later than in other regions of the continent.

methodsWe contacted 11 West African countries to collect information about their influenza surveillance systems (number of sites, type of surveillance, sampling strategy, populations sampled, case definitions used, number of specimens collected and number of specimens positive for influenza viruses) for the time period January 2010 through December 2012.

resultsOf the 11 countries contacted, 8 responded: Burkina Faso, Cote d'Ivoire, Mali, Mauritania, Niger, Nigeria, Sierra Leone and Togo. Countries used standard World Health Organization (WHO) case definitions for influenza-like illness (ILI) and severe acute respiratory illness (SARI) or slight variations thereof. There were 70 surveillance sites: 26 SARI and 44 ILI. Seven countries conducted SARI surveillance and collected 3114 specimens of which 209 (7%) were positive for influenza viruses. Among influenza-positive SARI patients, 132 (63%) were influenza A [68 influenza A(H1N1)pdm09, 64 influenza A(H3N2)] and 77 (37%) were influenza B. All eight countries conducted ILI surveillance and collected 20,375 specimens, of which 2278 (11%) were positive for influenza viruses. Among influenza-positive ILI patients, 1431 (63%) were influenza A [820 influenza A(H1N1)pdm09, 611 influenza A(H3N2)] and 847 (37%) were influenza B. A majority of SARI and ILI case-patients who tested positive for influenza (72% SARI and 59% ILI) were children aged 0-4 years, as were a majority of those enrolled in surveillance. The seasonality of influenza and the predominant influenza type or subtype varied by country and year.

conclusionsInfluenza A(H1N1)pdm09 continued to circulate in West Africa along with influenza A(H3N2) and influenza B during 2010-2012. Although ILI surveillance systems produced a robust number of samples during the study period, more could be done to strengthen surveillance among hospitalized SARI case-patients. Surveillance systems captured young children but lacked data on adults and the elderly. More data on risk groups for severe influenza in West Africa are needed to help shape influenza prevention and clinical management policies and guidelines.

Indexed as

AdolescentAdultAfrica, WesternAgedChildChild, PreschoolFemaleHumansInfantInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza, HumanMaleMiddle AgedSeasonsSevere Acute Respiratory SyndromeEpidemiologyInfluenzaWest Africa

Identifiers

PMID29202715
PMCPMC5716025
OpenAlexW2773748522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.